YCR087C-A Antibody

What is YCR087C-A protein and why is it studied in Saccharomyces cerevisiae research?

YCR087C-A refers to a gene that encodes the UPF0743 protein in Saccharomyces cerevisiae (baker's yeast), particularly in strain 204508/S288c. This protein is classified as a "hypothetical protein," indicating that its sequence has been predicted but its functions have not been fully characterized . Researchers study this protein to understand genetic organization, protein function, and cellular processes in this model organism. The UPF0743 family designation suggests it belongs to a group of uncharacterized proteins with functions that remain to be elucidated, making it an interesting target for basic research into novel cellular mechanisms.

How is the YCR087C-A antibody produced and what are its basic characteristics?

The commercially available YCR087C-A antibody is typically produced as a polyclonal antibody in rabbits through antigen-affinity purification techniques . The production process involves immunizing rabbits with a specific antigen derived from the YCR087C-A protein, followed by collection and purification of the resulting antibodies. These antibodies belong to the IgG isotype and are specifically reactive against Saccharomyces cerevisiae strain 204508/S288c . The purity of research-grade antibodies is generally ≥85% as determined by SDS-PAGE analysis, which ensures consistent experimental results .

What applications is the YCR087C-A antibody validated for in yeast research?

The YCR087C-A antibody has been validated for several key applications in yeast research, with the primary applications being ELISA (Enzyme-Linked Immunosorbent Assay) and Western Blot (WB) . In ELISA applications, the antibody enables quantitative detection of the target protein in complex samples, while Western Blotting allows for size-based separation and identification of the protein. These techniques are fundamental for studying protein expression, regulation, and modification in Saccharomyces cerevisiae. The antibody's high specificity makes it suitable for detecting endogenous levels of YCR087C-A protein in yeast lysates and other sample preparations.

What is the difference between monoclonal and polyclonal YCR087C-A antibodies?

While the commercially available YCR087C-A antibody is primarily produced as a polyclonal preparation in rabbits , understanding the differences between monoclonal and polyclonal antibodies is important for experimental planning:

Polyclonal antibodies like the rabbit anti-YCR087C-A offer advantages in detection sensitivity through recognition of multiple epitopes, while theoretical monoclonal versions would provide higher specificity at the cost of potentially reduced sensitivity.

How can YCR087C-A antibody be used to investigate protein-protein interactions in yeast?

To investigate protein-protein interactions involving the YCR087C-A protein, researchers can employ co-immunoprecipitation (Co-IP) techniques with the YCR087C-A antibody. The methodology involves:

• Preparing yeast cell lysates under non-denaturing conditions to preserve protein complexes

• Incubating the lysate with the YCR087C-A antibody to capture the target protein and its interacting partners

• Adding Protein A/G beads to precipitate the antibody-protein complexes

• Washing to remove non-specifically bound proteins

• Eluting the protein complexes and analyzing by SDS-PAGE and Western blotting with antibodies against suspected interaction partners

For quantitative assessment, techniques like proximity ligation assay (PLA) can be used with the YCR087C-A antibody in combination with antibodies against putative interaction partners. When interpreting results, it's critical to include appropriate negative controls, such as immunoprecipitation with non-specific IgG, to account for non-specific binding that may occur with the antigen-affinity purified antibody .

What are the considerations for using YCR087C-A antibody in chromatin immunoprecipitation (ChIP) experiments?

When adapting the YCR087C-A antibody for ChIP experiments to investigate potential DNA interactions, researchers should consider several important factors:

• Crosslinking optimization: Test different formaldehyde concentrations (typically 1-3%) and incubation times to effectively crosslink YCR087C-A to DNA if interactions exist.

• Sonication conditions: Optimize sonication parameters to generate DNA fragments of 200-500 bp for effective immunoprecipitation.

• Antibody validation: Verify the YCR087C-A antibody's efficiency in immunoprecipitating the native, crosslinked protein using Western blot before proceeding with ChIP.

• Controls: Always include:

  • Input samples (pre-immunoprecipitated chromatin)

  • IgG negative control (same isotype as the YCR087C-A antibody)

  • Positive control using an antibody against a known DNA-binding protein

• Antibody amount: Typically 2-5 μg of antibody per ChIP reaction, though this should be empirically determined for the YCR087C-A antibody.

The antigen-affinity purification of the commercially available antibody makes it potentially suitable for ChIP applications, though researchers should conduct preliminary validation experiments to confirm its performance in this specific context .

How does YCR087C-A antibody perform in immunofluorescence microscopy for localization studies?

While the YCR087C-A antibody is primarily validated for ELISA and Western blot applications , researchers interested in immunofluorescence microscopy studies should follow this optimization protocol:

• Fixation optimization:

  • Test multiple fixation methods (formaldehyde, methanol, or combination)

  • Typical starting point: 4% paraformaldehyde for 15-20 minutes at room temperature

• Permeabilization:

  • For yeast cells, test zymolyase treatment followed by detergent permeabilization

  • Try different detergents (0.1-0.5% Triton X-100, 0.1-0.5% Saponin)

• Blocking:

  • Use 1-5% BSA or 5-10% normal serum from a species different from the antibody host

  • Include 0.1% Tween-20 to reduce background

• Antibody dilution:

  • Begin with 1:100-1:500 dilution of the YCR087C-A antibody

  • Incubate overnight at 4°C for optimal signal

• Controls:

  • Include no-primary-antibody control

  • Use wild-type and YCR087C-A deletion strains for specificity validation

• Signal enhancement (if needed):

  • Consider tyramide signal amplification

  • Use high-sensitivity detection systems

It's advisable to validate any subcellular localization findings with complementary approaches such as epitope tagging and fluorescent protein fusions, as antibody accessibility can vary in different cellular compartments.

What cross-reactivity might be expected when using YCR087C-A antibody in non-S288c yeast strains?

The YCR087C-A antibody is specifically designed to target the UPF0743 protein in Saccharomyces cerevisiae strain 204508/S288c (Baker's yeast) . When using this antibody in non-S288c strains, researchers should consider potential cross-reactivity issues:

• Sequence homology assessment: Before experimental use, compare the YCR087C-A protein sequence between S288c and the target strain using bioinformatics tools. Higher sequence identity (>90%) suggests better recognition.

• Epitope conservation: The antibody recognition may depend on specific epitopes within the protein. Even small sequence variations in these regions can significantly affect antibody binding.

• Validation approach:

  • Perform Western blot analysis comparing the S288c strain (positive control) with the non-S288c strain

  • Look for differences in band intensity, molecular weight, or additional bands

  • Include a YCR087C-A deletion strain as a negative control

• Possible outcomes and interpretations:

When working with clinical or environmental isolates, preliminary testing is essential as these strains can have significant genetic diversity compared to laboratory reference strains.

What are the optimal conditions for Western blotting with YCR087C-A antibody?

For optimal Western blotting results with the YCR087C-A antibody, the following protocol is recommended:

• Sample preparation:

  • Extract yeast proteins using mechanical disruption (glass beads) or enzymatic lysis (zymolyase treatment)

  • Include protease inhibitors to prevent degradation

  • Denature samples in Laemmli buffer with 5% β-mercaptoethanol at 95°C for 5 minutes

• Gel electrophoresis:

  • Use 12-15% SDS-PAGE gels for optimal resolution of the YCR087C-A protein

  • Load 20-50 μg of total protein per lane

• Transfer conditions:

  • Use PVDF membrane (0.45 μm pore size)

  • Transfer at 100V for 1 hour or 30V overnight at 4°C

  • Verify transfer efficiency with reversible staining (Ponceau S)

• Blocking:

  • Block with 5% non-fat dry milk or 3-5% BSA in TBST (TBS with 0.1% Tween-20) for 1 hour at room temperature

• Primary antibody incubation:

  • Dilute YCR087C-A antibody 1:500 to 1:2000 in blocking buffer

  • Incubate overnight at 4°C with gentle rocking

• Washing and secondary antibody:

  • Wash 3x for 5-10 minutes each with TBST

  • Incubate with appropriate HRP-conjugated anti-rabbit secondary antibody (1:5000-1:10000) for 1 hour at room temperature

• Detection:

  • Use enhanced chemiluminescence (ECL) substrate

  • Expose to X-ray film or use a digital imaging system

This protocol should yield specific detection of YCR087C-A protein with minimal background, as the antibody has demonstrated specificity in Western blot applications .

How should samples be prepared for maximum detection sensitivity with YCR087C-A antibody in ELISA?

To achieve maximum detection sensitivity when using the YCR087C-A antibody in ELISA applications, implement the following sample preparation and assay optimization strategies:

• Yeast sample preparation:

  • Optimize cell lysis using a buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, and protease inhibitor cocktail

  • Clarify lysates by centrifugation at 12,000g for 15 minutes at 4°C

  • Quantify total protein concentration using BCA or Bradford assay

  • Prepare serial dilutions to determine optimal sample concentration

• ELISA protocol optimization:

  • Coating: Use high-binding ELISA plates coated with capture antibody (1-10 μg/ml) in carbonate buffer (pH 9.6) overnight at a4°C

  • Blocking: Block with 1-5% BSA in PBS for 1-2 hours at room temperature

  • Sample addition: Apply prepared samples for 1-2 hours at room temperature or overnight at 4°C

  • Detection: Use biotinylated detection antibody followed by streptavidin-HRP for signal amplification

  • Substrate: TMB substrate provides high sensitivity with colorimetric readout at 450 nm

• Antibody dilution optimization:

  • Test a range of dilutions (1:500 to 1:5000) of the YCR087C-A antibody

  • Create a standard curve using purified recombinant YCR087C-A protein

  • Use the alkaline phosphatase (AP)-conjugated detection system for enhanced sensitivity

• Signal enhancement strategies:

  • Implement sandwich ELISA format for improved sensitivity

  • Consider avidin-biotin amplification systems

  • Use prolonged substrate development times with kinetic readings

• Validation controls:

  • Include wild-type yeast extracts as positive control

  • Use YCR087C-A knockout strain extracts as negative control

  • Include reagent blanks and standard curves in each assay

This methodology aligns with standard ELISA procedures adapted specifically for the YCR087C-A antibody, which has been validated for ELISA applications .

What controls are essential when validating experimental results using YCR087C-A antibody?

Proper controls are critical for validating results obtained with the YCR087C-A antibody. Implement these controls to ensure reliable and interpretable data:

• Antibody specificity controls:

  • Negative genetic control: Use extracts from YCR087C-A deletion strain to confirm antibody specificity

  • Peptide competition assay: Pre-incubate antibody with excess purified antigen before application to block specific binding

  • Secondary antibody only: Omit primary antibody to identify non-specific binding of secondary antibody

• Sample processing controls:

  • Input control: Reserve a portion of pre-immunoprecipitated sample for total protein analysis

  • Isotype control: Use non-specific rabbit IgG at the same concentration as YCR087C-A antibody

  • Loading control: Include detection of a housekeeping protein (e.g., actin, GAPDH) to normalize for loading variations

• Technical and biological replicates:

  • Technical replicates: Minimum of 3 per sample to assess method variability

  • Biological replicates: Independent yeast cultures to account for biological variation

• Validation across methods:

  • Orthogonal techniques: Confirm key findings using alternative detection methods

  • Multiple antibody approach: When possible, use antibodies targeting different epitopes of YCR087C-A

• Quantification controls:

  • Standard curve: Use purified recombinant YCR087C-A protein at known concentrations

  • Dynamic range assessment: Ensure detection falls within the linear range of the assay

Implementation of these controls is essential for establishing the validity of experimental findings and addressing potential sources of error or artifact when working with the YCR087C-A antibody.

How can epitope mapping be performed to characterize the binding site of YCR087C-A antibody?

Epitope mapping of the YCR087C-A antibody provides valuable information about its specificity and can guide experimental design. Here's a comprehensive methodology for epitope mapping:

• Peptide array analysis:

  • Generate overlapping synthetic peptides (15-20 amino acids) spanning the entire YCR087C-A protein sequence

  • Spot peptides onto membrane support

  • Probe with the YCR087C-A antibody using standard immunoblotting techniques

  • Identify peptides that show positive reactivity

• Alanine scanning mutagenesis:

  • Create a series of recombinant YCR087C-A proteins with single alanine substitutions

  • Express and purify these mutant proteins

  • Test antibody binding using ELISA or Western blot

  • Identify residues critical for antibody recognition

• Phage display method:

  • Screen a random peptide phage display library with the YCR087C-A antibody

  • After multiple rounds of biopanning, sequence positive phage clones

  • Analyze consensus sequences to identify the epitope

• Hydrogen/deuterium exchange mass spectrometry (HDX-MS):

  • Compare hydrogen/deuterium exchange rates of YCR087C-A protein alone versus antibody-bound state

  • Regions with reduced exchange when antibody is bound indicate the epitope

• X-ray crystallography:

  • Crystallize the antibody-antigen complex

  • Determine the structure to identify precise molecular interactions

  • Similar to the approach used in for other antibody-antigen complexes

• Computational prediction and validation:

  • Use epitope prediction algorithms based on protein sequence

  • Validate predictions experimentally using synthesized peptides

  • Compare results with experimental mapping

Understanding the epitope can help explain cross-reactivity patterns, predict antibody performance in different applications, and guide the development of improved antibodies with enhanced specificity or broader strain recognition.

What are common causes of weak or absent signals when using YCR087C-A antibody in Western blots?

When troubleshooting weak or absent signals in Western blots with YCR087C-A antibody, consider these common issues and solutions:

The YCR087C-A protein might have low endogenous expression, so enrichment techniques may be necessary. The antibody's antigen-affinity purification should provide sufficient specificity for detection in properly prepared yeast samples .

How can background issues be addressed when using YCR087C-A antibody in immunohistochemistry?

While the YCR087C-A antibody is primarily validated for ELISA and Western blot applications , researchers adapting it for immunohistochemistry (IHC) or immunocytochemistry (ICC) may encounter background issues. Here's a systematic approach to minimize background:

• Fixation optimization:

  • Test different fixatives (formaldehyde, methanol, acetone)

  • Optimize fixation time (typically 10-20 minutes for yeast cells)

  • Try fresh fixative solutions to prevent background caused by over-fixation

• Blocking optimization:

  • Increase blocking agent concentration (try 5-10% normal serum)

  • Extend blocking time to 2 hours at room temperature

  • Add 0.1-0.3% Triton X-100 to blocking buffer for improved penetration

• Antibody dilution and incubation:

  • Test more dilute antibody solutions (1:500-1:2000)

  • Extend washing steps (5 washes of 5 minutes each)

  • Prepare antibody dilutions in buffer containing 0.1-0.2% BSA and 0.05-0.1% Tween-20

• Endogenous enzyme blocking:

  • For peroxidase-based detection, block endogenous peroxidase with 3% H₂O₂ for 10 minutes

  • For alkaline phosphatase-based detection, add levamisole to block endogenous phosphatase

• Autofluorescence reduction (for fluorescent detection):

  • Treat samples with 0.1% sodium borohydride for 5 minutes

  • Use Sudan Black B (0.1-0.3% in 70% ethanol) for 10 minutes

  • Consider spectral unmixing during image acquisition

• Signal-to-noise enhancement:

  • Use biotin-streptavidin amplification systems carefully (can increase background)

  • Consider tyramide signal amplification for weak signals

  • Use secondary antibodies with minimal cross-reactivity to yeast proteins

• Controls for troubleshooting:

  • Include secondary antibody-only control

  • Use YCR087C-A knockout strain as negative control

  • Process wild-type samples without primary antibody to assess non-specific binding

By systematically addressing these factors, researchers can optimize conditions for using the YCR087C-A antibody in immunohistochemical applications beyond its validated ELISA and Western blot uses.

What approaches can resolve contradictory results between YCR087C-A antibody detection and other protein detection methods?

When faced with contradictory results between YCR087C-A antibody detection and alternative protein detection methods, implement this systematic investigation approach:

• Verify antibody specificity:

  • Perform Western blot using wild-type and YCR087C-A deletion strains

  • Conduct peptide competition assays to confirm binding specificity

  • Test multiple lots of the antibody if available to rule out lot-to-lot variation

• Evaluate alternative methods:

  • If using epitope-tagged YCR087C-A, verify that the tag doesn't affect protein function or expression

  • For contradictions with mass spectrometry data, check sample preparation differences

  • When comparing with fluorescent protein fusions, ensure the fusion doesn't alter localization or stability

• Investigate biological and technical variables:

  • Growth conditions: Compare the exact growth conditions between experiments

  • Cell cycle effects: Synchronize cultures to rule out cell cycle-dependent expression

  • Strain background: Confirm genetic background is identical between experiments

• Reconciliation strategies:

  • For quantitative discrepancies: Calibrate antibody detection against a purified standard curve

  • For localization differences: Use fractionation followed by Western blot to confirm biochemical localization

  • For expression timing conflicts: Perform time-course experiments with tight sampling intervals

• Methodological approach for resolution:

  • Design experiments where multiple detection methods are used on the same samples

  • Implement concordance analysis across methods

  • Consider the possibility that both results are correct but reflecting different aspects of biology (e.g., different isoforms, post-translational modifications)

• Advanced reconciliation techniques:

  • Immunoprecipitation followed by mass spectrometry for definitive identification

  • CRISPR-mediated endogenous tagging to create reference standards

  • Absolute quantification using approaches like Selected Reaction Monitoring (SRM)

This methodological framework allows for systematic investigation of contradictory results, leading to better understanding of the underlying biology and technical limitations of different detection methods .

How should quantitative data from YCR087C-A antibody experiments be normalized for comparative studies?

Proper normalization is essential for meaningful quantitative comparisons across different experiments using the YCR087C-A antibody. Implement these normalization strategies based on the experimental context:

• Western blot quantification:

  • Loading control normalization: Express YCR087C-A signal relative to housekeeping proteins (e.g., actin, GAPDH, tubulin)

  • Total protein normalization: Use stain-free gels or Ponceau S staining to measure total protein in each lane

  • Internal reference: Include a constant amount of recombinant YCR087C-A protein as an internal standard

• ELISA quantification:

  • Standard curve approach: Generate a standard curve using purified recombinant YCR087C-A protein

  • Parallel line analysis: Compare dose-response curves between samples and standards

  • Total protein normalization: Express results as amount of YCR087C-A per mg of total protein

• Immunofluorescence quantification:

  • Cell size normalization: Normalize signal intensity to cell or nuclear area

  • Reference channel: Include a stable marker as reference channel for ratio imaging

  • Control sample normalization: Express results as fold-change relative to control condition

• Statistical approaches for normalization:

  • Z-score transformation: Convert raw data to standard deviations from the mean

  • Quantile normalization: Adjust distributions to be identical across samples

  • LOESS regression: Apply locally weighted regression for systematic bias correction

• Experimental design considerations:

  • Include technical replicates (minimum of 3) within each experiment

  • Perform biological replicates (minimum of 3) with independent cultures

  • Design experiments with paired controls whenever possible

• Reporting normalized data:

When reporting results, always clearly state the normalization method used, include raw data in supplementary materials when possible, and provide sufficient methodological detail to enable reproducibility .